| (+)-Magnoflorine |
|
|
|
|
|
|
|
|
|
| (R)-Selisistat |
|
|
|
|
|
|
|
|
98.03% |
| (S)-Selisistat |
|
|
|
|
|
|
|
|
99.39% |
| Tetramethyluric acid |
|
|
|
|
|
|
|
|
99.63% |
| 2"-O-Galloylhyperin |
|
|
|
|
|
|
|
|
99.57% |
| 2"-O-Galloylhyperin (Standard) |
|
|
|
|
|
|
|
|
|
| 2'/3'-O-Acetyl-ADP-ribose sodium |
|
|
|
|
|
|
|
|
|
| Fisetin quarterhydrate |
|
|
|
|
|
|
|
|
95.89% |
| 2-APQC |
|
|
|
|
|
|
|
|
99.70% |
| 3-TYP |
|
|
|
|
|
|
|
|
99.90% |
| 3-TYP (Standard) |
|
|
|
|
|
|
|
|
|
| 3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol |
|
|
|
|
|
|
|
|
|
| 4'-Bromo-resveratrol |
|
|
|
|
|
|
|
|
99.94% |
| 4-Hydroxyestrone |
|
|
|
|
|
|
|
|
98.77% |
| 4-Hydroxyestrone-13C6 |
|
|
|
|
|
|
|
|
|
| 4-Hydroxyestrone-d4 |
|
|
|
|
|
|
|
|
99.35% |
| 5-Heptadecylresorcinol |
|
|
|
|
|
|
|
|
99.83% |
| 6,7-Dimethoxy-1,3-bis(4-methoxyphenyl)isoquinoline |
|
|
|
|
|
|
|
|
|
| 7-Chloro-4-(piperazin-1-yl)quinoline |
|
|
|
|
|
|
|
|
98.63% |
| 8-Prenylnaringenin |
|
|
|
|
|
|
|
|
99.63% |
| 8AQ−Cu−5Iu |
|
|
|
|
|
|
|
|
|
| A1B11 |
|
|
|
|
|
|
|
|
|
| A2B57 |
|
|
|
|
|
|
|
|
|
| AC-93253 |
|
|
|
|
|
|
|
|
|
| Ac-QPKK(Ac)-AMC |
|
|
|
|
|
|
|
|
|
| Ac-QPKK(Ac)-AMC acetate |
|
|
|
|
|
|
|
|
99.38% |
| Ac-RHKK(Ac)-AMC |
|
|
|
|
|
|
|
|
99.68% |
| AdipoR agonist 1 |
|
|
|
|
|
|
|
|
|
| ADTL-SA1215 |
|
|
|
|
|
|
|
|
98.96% |
| Agalloside |
|
|
|
|
|
|
|
|
98.0% |
| AGK2 |
|
|
|
|
|
|
|
|
99.43% |
| AGK7 |
|
|
|
|
|
|
|
|
|
| AK-1 |
|
|
|
|
|
|
|
|
99.84% |
| AK-7 |
|
|
|
|
|
|
|
|
99.63% |
| Altissimacoumarin F |
|
|
|
|
|
|
|
|
|
| Antileishmanial agent-44 |
|
|
|
|
|
|
|
|
|
| Antiproliferative agent-17 |
|
|
|
|
|
|
|
|
|
| Arecaidine-propargyl ester |
|
|
|
|
|
|
|
|
|
| Aristoforin |
|
|
|
|
|
|
|
|
|
| BF-175 |
|
|
|
|
|
|
|
|
|
| BML-278 |
|
|
|
|
|
|
|
|
98.49% |
| Butrin |
|
|
|
|
|
|
|
|
|
| C1A |
|
|
|
|
|
|
|
|
|
| Cambinol |
|
|
|
|
|
|
|
|
99.89% |
| Cannabisin F |
|
|
|
|
|
|
|
|
96.0% |
| CAY10602 |
|
|
|
|
|
|
|
|
98.69% |
| CHIC35 |
|
|
|
|
|
|
|
|
|
| Cholesterol sulfate |
|
|
|
|
|
|
|
|
|
| Cholesterol sulfate-d7 sodium |
|
|
|
|
|
|
|
|
99.70% |
| Cholesteryl sulfate sodium |
|
|
|
|
|
|
|
|
99.86% |
| Citriniorl A |
|
|
|
|
|
|
|
|
|
| CL5D |
|
|
|
|
|
|
|
|
|
| CrBKA |
|
|
|
|
|
|
|
|
98.46% |
| Croconic acid disodium |
|
|
|
|
|
|
|
|
99.98% |
| Cudraflavone B |
|
|
|
|
|
|
|
|
|
| CypD-IN-5 |
|
|
|
|
|
|
|
|
|
| D-Galacto-D-mannan |
|
|
|
|
|
|
|
|
|
| DCHC |
|
|
|
|
|
|
|
|
|
| DDL-218 |
|
|
|
|
|
|
|
|
99.49% |
| E1231 |
|
|
|
|
|
|
|
|
98.46% |
| Epigenetic factor-IN-1 |
|
|
|
|
|
|
|
|
|
| Et-29 |
|
|
|
|
|
|
|
|
99.89% |
| F0911-7667 |
|
|
|
|
|
|
|
|
|
| FLS-359 |
|
|
|
|
|
|
|
|
95.41% |
| Gamma-glutamylcysteine ammonium |
|
|
|
|
|
|
|
|
|
| Guttiferone G |
|
|
|
|
|
|
|
|
|
| Gypenoside CII |
|
|
|
|
|
|
|
|
|
| hsa62 |
|
|
|
|
|
|
|
|
|
| HSP70/SIRT2-IN-1 |
|
|
|
|
|
|
|
|
|
| HSP70/SIRT2-IN-2 |
|
|
|
|
|
|
|
|
|
| IMU-856 |
|
|
|
|
|
|
|
|
|
| Inauhzin |
|
|
|
|
|
|
|
|
98.46% |
| JFD00244 |
|
|
|
|
|
|
|
|
99.40% |
| JGB1741 |
|
|
|
|
|
|
|
|
99.37% |
| Loliolide |
|
|
|
|
|
|
|
|
99.92% |
| MC3138 |
|
|
|
|
|
|
|
|
99.92% |
| MC3482 |
|
|
|
|
|
|
|
|
98.55% |
| MDL-800 |
|
|
|
|
|
|
|
|
99.11% |
| MDL-811 |
|
|
|
|
|
|
|
|
99.68% |
| MI-217 |
|
|
|
|
|
|
|
|
99.52% |
| MIND4-19 |
|
|
|
|
|
|
|
|
99.93% |
| Mito-Esculetin |
|
|
|
|
|
|
|
|
|
| MitoPBN |
|
|
|
|
|
|
|
|
95.00% |
| Myricanol |
|
|
|
|
|
|
|
|
98.93% |
| Mz325 |
|
|
|
|
|
|
|
|
98.10% |
| NCO-141 |
|
|
|
|
|
|
|
|
|
| NCO-90 |
|
|
|
|
|
|
|
|
|
| Neutrophil elastase inhibitor 5 |
|
|
|
|
|
|
|
|
95.74% |
| NH4-6 |
|
|
|
|
|
|
|
|
|
| Nicotinamide riboside triflate |
|
|
|
|
|
|
|
|
|
| Nicotinic acid mononucleotide |
|
|
|
|
|
|
|
|
98.08% |
| Nicotinic acid mononucleotide triethylamine |
|
|
|
|
|
|
|
|
99.36% |
| NSC 90469 |
|
|
|
|
|
|
|
|
99.41% |
| OSS_128167 |
|
|
|
|
|
|
|
|
98.92% |
| OSS_128167 (Standard) |
|
|
|
|
|
|
|
|
|
| OXPHOS-IN-3 |
|
|
|
|
|
|
|
|
|
| Palmitoyl tetrapeptide-20 |
|
|
|
|
|
|
|
|
99.21% |
| Palmitoyl tetrapeptide-20 TFA |
|
|
|
|
|
|
|
|
|
| Pegloxenatide |
|
|
|
|
|
|
|
|
90.00% |
| Phoenixin-14 |
|
|
|
|
|
|
|
|
99.28% |
| Phoenixin-14 TFA |
|
|
|
|
|
|
|
|
|
| Plantainoside D |
|
|
|
|
|
|
|
|
99.15% |
| PRMT/HKMT-IN-1 |
|
|
|
|
|
|
|
|
|
| PROTAC Sirt2 Degrader-1 |
|
|
|
|
|
|
|
|
99.09% |
| PROTAC Sirt2 Degrader-2 |
|
|
|
|
|
|
|
|
|
| Rencofilstat |
|
|
|
|
|
|
|
|
90.29% |
| Resveratrol |
|
|
|
|
|
|
|
|
|
| Resveratrol analog 1 |
|
|
|
|
|
|
|
|
98.40% |
| Resveratrol analog 2 |
|
|
|
|
|
|
|
|
|
| RK-9123016 |
|
|
|
|
|
|
|
|
99.65% |
| Salermide |
|
|
|
|
|
|
|
|
98.0% |
| Selaginellin |
|
|
|
|
|
|
|
|
|
| Selisistat |
|
|
|
|
|
|
|
|
99.92% |
| SirReal-1 |
|
|
|
|
|
|
|
|
99.82% |
| SirReal1-O-propargyl |
|
|
|
|
|
|
|
|
|
| SirReal2 |
|
|
|
|
|
|
|
|
99.0% |
| SIRT-IN-1 |
|
|
|
|
|
|
|
|
98.14% |
| SIRT-IN-2 |
|
|
|
|
|
|
|
|
98.08% |
| SIRT-IN-3 |
|
|
|
|
|
|
|
|
98.10% |
| SIRT-IN-4 |
|
|
|
|
|
|
|
|
|
| SIRT-IN-5 |
|
|
|
|
|
|
|
|
|
| SIRT-IN-6 |
|
|
|
|
|
|
|
|
|
| SIRT-IN-7 |
|
|
|
|
|
|
|
|
|
| SIRT1 activator 1 |
|
|
|
|
|
|
|
|
|
| SIRT1 activator 2 |
|
|
|
|
|
|
|
|
99.28% |
| SIRT1 activator 3 |
|
|
|
|
|
|
|
|
99.9% |
| SIRT1 activator 4 |
|
|
|
|
|
|
|
|
|
| SIRT1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT1-IN-1 |
|
|
|
|
|
|
|
|
98.15% |
| SIRT1-IN-2 |
|
|
|
|
|
|
|
|
98.31% |
| SIRT1-IN-3 |
|
|
|
|
|
|
|
|
99.12% |
| SIRT1-IN-4 |
|
|
|
|
|
|
|
|
98.62% |
| SIRT1-IN-5 |
|
|
|
|
|
|
|
|
|
| SIRT1-IN-6 |
|
|
|
|
|
|
|
|
|
| Sirt1/2-IN-1 |
|
|
|
|
|
|
|
|
|
| Sirt1/2-IN-2 |
|
|
|
|
|
|
|
|
90% |
| Sirt1/2-IN-3 |
|
|
|
|
|
|
|
|
|
| Sirt1/2-IN-4 |
|
|
|
|
|
|
|
|
|
| Sirt1/2-IN-5 |
|
|
|
|
|
|
|
|
|
| SIRT1/2/3-IN-2 |
|
|
|
|
|
|
|
|
|
| Sirt2-IN-1 |
|
|
|
|
|
|
|
|
98.71% |
| SIRT2-IN-10 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-11 |
|
|
|
|
|
|
|
|
99.94% |
| SIRT2-IN-12 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-13 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-14 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-15 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-16 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-17 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-18 |
|
|
|
|
|
|
|
|
|
| Sirt2-IN-2 |
|
|
|
|
|
|
|
|
99.80% |
| Sirt2-IN-5 |
|
|
|
|
|
|
|
|
|
| Sirt2-IN-6 |
|
|
|
|
|
|
|
|
|
| Sirt2-IN-7 |
|
|
|
|
|
|
|
|
|
| SIRT2-IN-8 |
|
|
|
|
|
|
|
|
98.45% |
| SIRT2-IN-9 |
|
|
|
|
|
|
|
|
99.45% |
| SIRT2/6-IN-1 |
|
|
|
|
|
|
|
|
99.79% |
| SIRT3 activator 1 |
|
|
|
|
|
|
|
|
98.14% |
| SIRT3 activator 2 |
|
|
|
|
|
|
|
|
98.94% |
| SIRT3 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| Sirt3 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT3-IN-1 |
|
|
|
|
|
|
|
|
98.47% |
| SIRT3-IN-2 |
|
|
|
|
|
|
|
|
|
| SIRT4-IN-1 |
|
|
|
|
|
|
|
|
99.94% |
| SIRT5 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 1 |
|
|
|
|
|
|
|
|
98.67% |
| SIRT5 inhibitor 2 |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 3 |
|
|
|
|
|
|
|
|
98.0% |
| SIRT5 inhibitor 4 |
|
|
|
|
|
|
|
|
98.37% |
| SIRT5 inhibitor 5 |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 6 |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 7 |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 8 |
|
|
|
|
|
|
|
|
|
| SIRT5 inhibitor 9 |
|
|
|
|
|
|
|
|
|
| Sirt5 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| Sirt5 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT5-IN-10 |
|
|
|
|
|
|
|
|
|
| SIRT6 activator 12q |
|
|
|
|
|
|
|
|
99.83% |
| SIRT6 activator 2 |
|
|
|
|
|
|
|
|
|
| SIRT6 activator 3 |
|
|
|
|
|
|
|
|
|
| SIRT6 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT6 modulator-1 |
|
|
|
|
|
|
|
|
|
| Sirt6 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT6-IN-2 |
|
|
|
|
|
|
|
|
99.92% |
| SIRT6-IN-3 |
|
|
|
|
|
|
|
|
98.19% |
| SIRT6-IN-4 |
|
|
|
|
|
|
|
|
|
| SIRT6-IN-5 |
|
|
|
|
|
|
|
|
|
| SIRT6-IN-6 |
|
|
|
|
|
|
|
|
98.59% |
| SIRT7 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| SIRT7 inhibitor 97491 |
|
|
|
|
|
|
|
|
98.81% |
| Sirt7 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| Sirt7 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
| Sirtinol |
|
|
|
|
|
|
|
|
98.0% |
| Sirtuin modulator 1 |
|
|
|
|
|
|
|
|
99.85% |
| Sirtuin modulator 2 |
|
|
|
|
|
|
|
|
99.22% |
| Sirtuin modulator 3 |
|
|
|
|
|
|
|
|
99.32% |
| Sirtuin modulator 4 |
|
|
|
|
|
|
|
|
|
| Sirtuin modulator 5 |
|
|
|
|
|
|
|
|
|
| Sirtuin modulator 6 |
|
|
|
|
|
|
|
|
99.70% |
| Sirtuin modulator 8 |
|
|
|
|
|
|
|
|
96.24% |
| Sirtuin-1 inhibitor 1 |
|
|
|
|
|
|
|
|
98.09% |
| Sirtuin-IN-1 |
|
|
|
|
|
|
|
|
|
| Sirtuin-IN-2 |
|
|
|
|
|
|
|
|
|
| SJ-106C |
|
|
|
|
|
|
|
|
|
| SKLB-11A |
|
|
|
|
|
|
|
|
99.40% |
| SL010110 |
|
|
|
|
|
|
|
|
|
| SPC-180002 |
|
|
|
|
|
|
|
|
|
| SR94 |
|
|
|
|
|
|
|
|
|
| SRT 1460 |
|
|
|
|
|
|
|
|
98.16% |
| SRT 1720 |
|
|
|
|
|
|
|
|
99.90% |
| SRT 1720 dihydrochloride |
|
|
|
|
|
|
|
|
99.60% |
| SRT 1720 monohydrochloride |
|
|
|
|
|
|
|
|
99.37% |
| SRT 2104 |
|
|
|
|
|
|
|
|
99.27% |
| SRT 2183 |
|
|
|
|
|
|
|
|
98.06% |
| SRT3657 |
|
|
|
|
|
|
|
|
|
| SRTCX1002 |
|
|
|
|
|
|
|
|
|
| SRTCX1003 |
|
|
|
|
|
|
|
|
|
| Sudachitin |
|
|
|
|
|
|
|
|
|
| Sweroside |
|
|
|
|
|
|
|
|
99.76% |
| Sweroside (Standard) |
|
|
|
|
|
|
|
|
98% |
| SZU-B6 |
|
|
|
|
|
|
|
|
98.78% |
| Tenovin-1 |
|
|
|
|
|
|
|
|
99.88% |
| Tenovin-3 |
|
|
|
|
|
|
|
|
98.0% |
| Tenovin-6 |
|
|
|
|
|
|
|
|
98.00% |
| Tenovin-6 Hydrochloride |
|
|
|
|
|
|
|
|
98.88% |
| Tenovin-D3 hydrochloride |
|
|
|
|
|
|
|
|
|
| Thiomyristoyl |
|
|
|
|
|
|
|
|
98.23% |
| UBCS039 |
|
|
|
|
|
|
|
|
98.88% |
| WAY-354574 |
|
|
|
|
|
|
|
|
98.0% |
| YK-3-237 |
|
|
|
|
|
|
|
|
99.54% |
| YM-08 |
|
|
|
|
|
|
|
|
|
| YZL-51N |
|
|
|
|
|
|
|
|
95.0% |
| Z-MAL |
|
|
|
|
|
|
|
|
|
| Z26395438 |
|
|
|
|
|
|
|
|
99.59% |
| ZINC08792229 |
|
|
|
|
|
|
|
|
|
| ZINC08792355 |
|
|
|
|
|
|
|
|
|
| β-Patchoulene |
|
|
|
|
|
|
|
|
|
| β-Curcumene |
|
|
|
|
|
|
|
|
|
| Gamma-glutamylcysteine |
|
|
|
|
|
|
|
|
98.53% |
| Gamma-glutamylcysteine TFA |
|
|
|
|
|
|
|
|
96.68% |
| Scopolin |
|
|
|
|
|
|
|
|
99.65% |
| Tanshindiol C |
|
|
|
|
|
|
|
|
98.47% |
| Dihydrocoumarin |
|
|
|
|
|
|
|
|
99.68% |
| Schisanhenol |
|
|
|
|
|
|
|
|
99.99% |
| Geniposidic acid |
|
|
|
|
|
|
|
|
98.87% |
| Agrimol B |
|
|
|
|
|
|
|
|
99.50% |
| Ponicidin |
|
|
|
|
|
|
|
|
99.93% |
| Decapeptide-12 |
|
|
|
|
|
|
|
|
99.95% |
| Rehmannioside D |
|
|
|
|
|
|
|
|
99.89% |
| Perindopril |
|
|
|
|
|
|
|
|
99.85% |
| Perindopril-d5 |
|
|
|
|
|
|
|
|
|
| Perindopril erbumine |
|
|
|
|
|
|
|
|
99.98% |
| Perindopril-d3 erbumine |
|
|
|
|
|
|
|
|
|
| (+)-Magnoflorine chloride |
|
|
|
|
|
|
|
|
99.10% |
| Fisetin-d5 |
|
|
|
|
|
|
|
|
|
| Fisetin |
|
|
|
|
|
|
|
|
99.90% |
| Ganoderic acid D |
|
|
|
|
|
|
|
|
99.18% |
| Nicotinamide |
|
|
|
|
|
|
|
|
|
| Nicotinamide (Standard) |
|
|
|
|
|
|
|
|
99.85% |
| Nicotinamide-13C,15N |
|
|
|
|
|
|
|
|
|
| Nicotinamide-13C6 |
|
|
|
|
|
|
|
|
99.8% |
| Nicotinamide-15N,13C3 |
|
|
|
|
|
|
|
|
|
| Nicotinamide-d3 |
|
|
|
|
|
|
|
|
|
| Nicotinamide-d4 |
|
|
|
|
|
|
|
|
99.94% |
| Nicotinamide |
|
|
|
|
|
|
|
|
99.98% |
| Nicotinamide riboside |
|
|
|
|
|
|
|
|
|
| Nicotinamide riboside chloride |
|
|
|
|
|
|
|
|
99.90% |
| Nicotinamide riboside malate |
|
|
|
|
|
|
|
|
98.04% |
| Nicotinamide riboside tartrate |
|
|
|
|
|
|
|
|
98.07% |
| Nicotinamide hydrochloride |
|
|
|
|
|
|
|
|
|
| Segetalin B |
|
|
|
|
|
|
|
|
99.9% |
| Cipepofol |
|
|
|
|
|
|
|
|
99.82% |
| Phellopterin |
|
|
|
|
|
|
|
|
99.94% |
| Licoisoflavone A |
|
|
|
|
|
|
|
|
99.53% |
| Resveratrol-13C6 |
|
|
|
|
|
|
|
|
|
| Resveratrol-d4 |
|
|
|
|
|
|
|
|
99.36% |
| Resveratrol (Standard) |
|
|
|
|
|
|
|
|
99.95% |
| Resveratrol |
|
|
|
|
|
|
|
|
99.95% |
| Withanoside IV |
|
|
|
|
|
|
|
|
98.47% |
| (+)-Magnoflorine iodide |
|
|
|
|
|
|
|
|
99.74% |
| Gypenoside XLIX |
|
|
|
|
|
|
|
|
99.88% |
| Suramin |
|
|
|
|
|
|
|
|
|
| Suramin sodium salt |
|
|
|
|
|
|
|
|
99.98% |
| Lumbokinase |
|
|
|
|
|
|
|
|
|
| Agkistrodon halys batroxobin |
|
|
|
|
|
|
|
|
95% |
| Schizophyllan |
|
|
|
|
|
|
|
|
|
| Ginkgolide C |
|
|
|
|
|
|
|
|
99.67% |
| Arjunolic acid |
|
|
|
|
|
|
|
|
98.17% |
| PDRN |
|
|
|
|
|
|
|
|
90.20% |
| Ophiopogonin D' |
|
|
|
|
|
|
|
|
99.94% |